Saturday 01 February 2025
As researchers continue to push the boundaries of artificial intelligence, a new study has shed light on the potential benefits and drawbacks of using AI-generated summaries for informed consent forms in clinical trials.
The study, which analyzed 11 clinical trial informed consent forms, found that AI-generated summaries were able to accurately capture key elements of the original text, including the purpose of the research, expected duration of participation, and potential risks and benefits. However, the accuracy of these summaries varied depending on the complexity of the original text and the level of human oversight involved.
One of the most significant findings was that AI-generated summaries were more accurate when used in conjunction with a sequential prompting approach, which involves breaking down complex text into smaller sections and using prompts to guide the AI’s understanding. This approach was found to be particularly effective for extracting key information from longer, more detailed informed consent forms.
The study also explored the use of multi-turn prompts, which involve asking follow-up questions to clarify ambiguous or unclear language. While this approach showed promise in improving the accuracy of AI-generated summaries, it also highlighted the need for further refinement and testing.
In addition to examining the technical aspects of AI-generated summaries, the study also delved into the human side of informed consent. Researchers surveyed patients who had participated in clinical trials and found that many were unaware of the true nature of their participation or the potential risks involved. This highlights the importance of clear communication and transparency in the informed consent process.
The study’s findings have significant implications for the use of AI-generated summaries in clinical trials. While AI has the potential to streamline the informed consent process and improve patient understanding, it is crucial that researchers prioritize accuracy, clarity, and human oversight to ensure that patients are fully informed and empowered to make informed decisions about their participation.
As the use of AI continues to evolve in healthcare, this study serves as a timely reminder of the importance of balancing technological advancements with human judgment and compassion. By prioritizing patient-centered approaches and incorporating AI-generated summaries into informed consent processes, researchers can work towards creating a more transparent, efficient, and patient-friendly clinical trial landscape.
Cite this article: “Balancing Technology and Transparency in Clinical Trial Informed Consent”, The Science Archive, 2025.
Clinical Trials, Ai-Generated Summaries, Informed Consent Forms, Research, Artificial Intelligence, Healthcare, Transparency, Patient Understanding, Human Oversight, Multi-Turn Prompts.
